The effects of adenosine on the human His-Purkinje system (HPS) were studied in nine patients with complete atrioventricular (AV) block. Adenosine had minimal effect on the control HPS cycle length, but in the presence of isoproterenol increased it from 906±183 to 1,449±350 ms, P < 0.001. Aminophylline, a competitive adenosine antagonist, completely abolished this antiadrenergic effect of adenosine.
Introduction
It is well recognized that many myocardial functions are regulated by the autonomic nervous system. A nonlinear antagonism between sympathetic stimulatory effects and inhibitory parasympathetic responses exists (1, 2) . Parasympathetic stimulation is thought to have a protective myocardial influence under hypoxic conditions, whereas sympathetic effects may create an unfavorable 02 supply-demand ratio (3) (4) (5) (6) ofthis function, vagal stimulation has a property thought to be unique to the autonomic nervous system, designated by Levy as accentuated antagonism (1, 2) . This term refers to the enhanced or augmented inhibitory myocardial response to vagal stimulation in the presence of background sympathetic tone, and is particularly evident in ventricular myocardium (7) (8) (9) (10) (11) (12) (13) (14) .
Although not as extensively studied, the intermediate metabolite adenosine, an endogenous nucleoside whose production is increased in response to ischemia or hypoxia (15) , has cardiac actions that in many respects resemble acetylcholine (ACh)-mediated' vagal effects. Experimentally, adenosine improves 02 supply through coronary vasodilation (16) and reduces 02 demand through its negative inotropic effects on atrial and ventricular myocardium (17, 18) . In addition, the electrophysiologic effects of adenosine on supraventricular tissues also reduce 02 demand (19) through its negative chronotropic (20) and dromotropic (21) effects in sinoatrial and atrioventricular (AV) nodal tissues, respectively. Like ACh, adenosine increases potassium conductance and hyperpolarizes supraventricular tissues toward the K+-equilibrium potential, Ek (22, 23) . Similar to ACh, these effects of adenosine are cAMP independent (i.e., direct effects) and are mediated through cell surface receptors that are coupled to a guanine nucleotide-binding regulatory protein, most likely Gi-3 (24) (25) (26) .
The effects and role of adenosine in ventricular myocardium and the His-Purkinje system (HPS) are not as well understood as those in supraventricular tissues. Experimentally, adenosine slows HPS automaticity both in isolated preparations and in vivo (27) (28) (29) (30) (31) , suggesting a direct effect in the absence of ,B-adrenergic cAMP stimulation in these tissues. Other studies in single isolated ventricular myocytes, however, indicate that adenosine has no direct effect but rather antagonizes the electrophysiologic effects of catecholamines that are mediated through stimulation of the adenylate cyclase-cAMP system (32, 33) , i.e., lengthening of action potential duration, positive displacement of the plateau phase, and delayed after depolarizations.
The purposes of this study were to (a) characterize the direct (cAMP-independent) and indirect (cAMP-dependent) electrophysiologic effects of adenosine in the human HPS and (b) determine the physiologic significance of adenosine's effects in these tissues. We hypothesized that, as in other myocardial tissues, adenosine functions in the HPS to reduce 02 demand. It was anticipated that adenosine would show minimal direct effects under basal conditions, but that during catecholamine stimulation and increased 02 demand adenosine would demonstrate accentuated antagonism to restore a favorable 02 supply-demand ratio.
Methods

Clinical protocol
All studies were performed with patients in the unsedated, postabsorp 35 .5±1 C.
The following procedure was used to produce complete AV block (30) . After an incision along the lateral margin of the right atrial appendage, an 8-0 silk suture was placed in the tip of the appendage for temporary retraction and access to the AV node area. An incision was then made anterior to the ostium of the coronary sinus above the insertion of the septal leaflet of the tricuspid valve.
Extracellular electrograms were recorded from the left atrium and His bundle as previously described (35) . Electrograms were amplified and displayed on a dual-beam oscilloscope (model 5110; Tektronix, Inc., Beaverton, OR) and recorded on a strip-chart recorder (model 220; Gould, Inc., Cleveland, OH). The rate of the escape rhythm (His bundle) was continuously monitored by a tachometer (Biotech, Gould Inc., Cleveland, OH) triggered by the ventricular deflection on the His bundle electrogram.
Isoproterenol (Sigma Chemical Co.) was infused for I min via a polyethylene catheter positioned in the aortic root above the coronary ostia at a concentration of 6 X 10-8 M. The His bundle rate was continuously monitored and multiple venous effluent samples (each sample was collected for 15 s) for measuring adenosine were obtained during and after the infusion.
To block the effects of adenosine, a novel alkylxanthine (1,3-di- propyl-8-phenylxanthine; BW A 1433) that binds to the adenosine Al receptor (36) (Table I) . Adenosine had a small but consistent effect on the -25 adenosine. After propranolol, the escape rhythm cycle length increased by 120 ms. Adenosine injection (300 mg) at this time had no further effect on the cycle length. Similar results were observed in patient 9 (Fig. 2) . Thus, the apparent "direct" effect of adenosine was completely abolished by pretreatment with propranolol. Parasympathetic blockade with atropine had minimal effect on the HPS rhythm. It decreased the cycle length from 1,536±124 to 1,485±128 ms (4.0±3.8%), P = 0.08 (Fig. 1) . QRS morphology and duration were unchanged by atropine. The effects of increased vagal tone on the escape rhythm were assessed in three patients. Valsalva maneuvers and right and left carotid sinus massage had no effect on the escape cycle length.
Antiadrenergic effects ofadenosine
Adrenergic stimulation of the HPS with isoproterenol markedly decreased the escape rhythm cycle length in eight patients from 1,521±121 to 906±183 ms, P = 0.0001. The mean decrease was 41±9.6% (Fig. 3) . In two patients the QRS duration was prolonged during isoproterenol stimulation suggesting either increased intraventricular conduction delay or preferential acceleration of an escape focus distal to the control site (Fig. 4) . Atrioventricular conduction was not restored in any patient during isoproterenol infusion.
Adenosine showed marked antiadrenergic effects on the HPS escape rhythm. In the presence of isoproterenol, doses of adenosine between 150 and 300 /Ag/kg decreased the escape cycle length by 61±31% from 906±183 to 1,449±350 ms, P < 0.001. In two patients the escape rhythm shifted to a more proximal but still infranodal site (same site as the control escape rhythm) in response to adenosine (Fig. 4) .
Antiadrenergic effects ofdipyridamole
The antiadrenergic effects of dipyridamole were evaluated in two patients. In the first patient (patient 8), during isoproterenol infusion (12 ,gg/ml) dipyridamole (0.56 mg/kg) increased the escape rhythm cycle length from 640 to 1,000 ms within 3 min (Fig. 5) 
Effects ofaminophylline
Adenosine either had no effect or minimal antiadrenergic effects on the HPS cycle length in the presence of both isoproterenol and aminophylline in five patients (Fig. 6 ), 1,020+94
(control) vs. 1,047±102 ms (adenosine), P = NS.
Isolated guinea pig hearts
The His bundle rhythm showed a time-dependent response to isoproterenol (Fig. 7 A) . The maximum rate response was ob- The adenosine antagonist BW A 1433 had no effect on the His bundle rate in the absence of isoproterenol, 101±3 beats/ min vs. 99±3 beats/min (control), P = NS (mean±SE); however, between 40 and 80 s after initiation of isoproterenol infusion the increase in His bundle rate was significantly greater in the presence of BW A 1433 than during control (Fig. 7 A) . Likewise, in comparison with control the isoproterenol-induced increase in His bundle rate (in the presence of BW A 1433) was associated with a greater release of adenosine in the venous effluent (Fig. 7 B) .
Discussion
A major finding of this study is that adenosine is an important antagonist of catecholamine-induced electrophysiologic effects in the human HPS. In contrast, adenosine has minimal direct effect on HPS automaticity. The primary effects of adenosine in the HPS are indirect or antiadrenergic. These findings are consistent with the phenomenon of accentuated antagonism, a term originally used to describe the enhanced inhibitory response of the myocardium to parasympathetic stimulation in the presence of sympathetic tone (1, 2) .
Evidence supporting accentuated antagonism
The effects of adenosine on HPS automaticity under basal conditions were abolished when two patients were pretreated with propranolol. These findings suggest that the apparent "direct" electrophysiologic actions of adenosine were in fact due to antagonism of endogenous catecholamine effects (Fig. 2) . Although adenosine has been reported to have significant direct effects in Purkinje tissue (27) (28) (29) (30) (31) , other studies in Purkinje fibers pretreated with propranolol (38) (32, 33) suggest that adenosine has minimal or no direct effect. The observed antiadrenergic effects of adenosine were consistent and reproducible in all patients. These antiadrenergic effects on HPS automaticity were antagonized by the xanthine derivative, aminophylline. Alkylxanthines are wellknown competitive adenosine antagonists (36) and have been shown to antagonize the negative dromotropic effects of adenosine at concentrations considerably lower than those required to either inhibit phosphodiesterase activity or to release catecholamines from nerve terminals (39) .
A unique finding in this study, although examined in only two patients, was that dipyridamole induced His-Purkinje slowing during isoproterenol infusion (Fig. 5) . Dipyridamole, a nucleoside transport blocker that potentiates the actions of adenosine (39) , has been shown to elevate plasma levels of adenosine in humans (40). In the absence of exogenous adenosine it is likely that dipyridamole potentiated the effects of endogenous adenosine released by isoproterenol (41), although direct negative chronotropic effects of dipyridamole independent of adenosine cannot be excluded (42) .
Previous clinical studies have shown that adenosine has significant negative chronotropic (43) and dromotropic effects in the sinoatrial and AV nodes (43, 44) . Adenosine is thought to have a direct action (effect in the absence of f-adrenergiccAMP stimulation) in these tissues by increasing steady state outward K+ current (22, 24). Similar to atrial muscarinic cholinergic receptors, the adenosine Al receptor is coupled to K+ channels via an inhibitory guanine nucleotide binding regulatory protein that mediates its effects independent of cAMP stimulation (24) (25) (26) . In contrast, the electrophysiologic actions of adenosine in the human HPS are primarily antiadrenergic and are consistent with the concept of accentuated antagonism. This phenomenon was originally observed for sympathetic-parasympathetic interactions in both in vitro and in vivo studies in ventricular muscle and Purkinje fibers (1, 2, (7) (8) (9) (10) (11) (12) (13) (14) and appears to serve as a protective mechanism for the ventricular myocardium from excessive catecholamine stimulation.
The likely cellular mechanism by which adenosine mediates accentuated antagonism involves the guanine nucleotidebinding regulatory protein (Gi) that couples the Al receptor with the catalytic subunit of adenylate cyclase to reduce cAMP levels (45) . Acetylcholine mediates its electrophysiologic effects on ventricular myocardium (accentuated antagonism) via an identical transduction process after binding to muscarinic cholinergic receptor (24, 46) . Adenosine has previously been described as having antiadrenergic activity with respect to its inotropic effects in ventricular myocardium (18, 41) . These effects are independent of muscarinic cholinergic stimulation (47) . Similar to its electrophysiologic action in the ventricle, adenosine has minimal effects on ventricular contractility in the absence of catecholamine stimulation and does not antagonize increased inotropy due to elevated extracellular [Ca2] (48) or a-adrenergic stimulation (49) . Attenuation ofthe contractile response to catecholamines by an increase in endogenous adenosine production is paralleled by a decrease in cellular cAMP levels (41) , suggesting that the antiadrenergic effects of adenosine are cAMP-dependent. Since catecholamines increase the rate of formation of adenosine in both hypoxic and normoxic hearts, it has been proposed by Schrader et al. (41) and Dobson et al. (17, 18) , that adenosine functions as a negative feedback inhibitor of catecholamine stimulation of myocardial contractility to attenuate adverse metabolic consequences.
To determine the physiologic role of adenosine's antiadrenergic activity in the HPS, a series of experiments was performed in normoxic guinea pig hearts. These studies were designed to demonstrate a negative feedback mechanism between adenosine and catecholamine-cAMP-mediated electrophysiologic effects on the HPS. Although catecholamine stimulation was shown to increase the chronotropic response of the HPS, this effect was amplified in the presence of the specific and potent adenosine antagonist, BW A1433 (Fig. 7 A) . Of significance is the finding that catecholamine-induced release of adenosine is also enhanced by the addition of BW A 1433 to the perfusate (Fig. 7 B) . Thus, by blocking the effects of adenosine at the receptor level with a resultant increase in adenosine release, the inhibitory effect of adenosine on catecholamine stimulation of HPS rate was uncoupled (therefore HPS rate increased). Since under these conditions release of the control signal (adenosine) was enhanced but its effector response blunted, a physiologic negative feedback control relationship between adenosine and catecholamines appears operative. Similarly, a positive feedback relationship between catecholamines and adenosines is suggested by the data demonstrating catecholamine-induced release of the nucleoside. These findings identify an important electrophysiologic role for adenosine in the HPS, that of a counterregulatory signal that protects the HPS from excessive catecholamine stimulation.
Autonomic effects on the HPS
As expected from in vivo canine studies, catecholamine infusion produced a dose-dependent increase in HPS automaticity (50, 51). Vagal maneuvers such as Valsalva and carotid sinus massage had little effect on the HPS rate. Consistent with the results from experimental studies, muscarinic cholinergic blockade with atropine had no effect on the HPS rate (52) (53) (54) .
There is extensive evidence confirming parasympathetic innervation of the mammalian ventricle as demonstrated by choline acetyltransferase activity, the presence of ACh, and muscarinic cholinergic receptors (55) (56) (57) (58) (59) . However, there are conflicting data regarding the importance of direct vagal effects in the ventricular myocardium and the HPS. Several studies have shown that vagal stimulation and ACh infusion exert a negative chronotropic effect on His-Purkinje tissues in vitro and in vivo (52, (60) (61) (62) (63) . In addition, ventricular refractory periods are shortened in response to atropine in patients pretreated with propranolol, suggesting a direct cholinergic effect in this tissue (64) . Despite these findings, however, the weight of evidence indicates that in ventricular myocardium vagal effects are primarily antiadrenergic (accentuated antagonism) (1, 2, (7) (8) (9) (10) (11) (12) (13) (14) . Vagal antagonism of sympathetic stimulation occurs at both pre-and postsynaptic levels (1, 2, 46 (66) or in previously infarcted hearts is arrhythmogenic (67, 68) . In contrast, increased vagal tone under these circumstances has a protective effect, decreasing the vulnerability for ventricular fibrillation (10, 67) . Adenosine is released from cardiac myocytes into the interstitium in response to ischemia, catecholamines, and ACh stimulation (69) . It 
Significance
The results of this study suggest that the primary electrophysiologic effect of adenosine in the human ventricular myocardium is to antagonize the effects of catecholamine stimulation of adenylate cyclase. It has been previously shown that exogenous adenosine effectively terminates ventricular tachycardia (VT) thought to be due to cAMP-mediated triggered activity (32, 33, 70 ). The present study shows that automatic rhythms originating from the HPS that are mediated by catecholamine stimulation of cAMP are also sensitive to adenosine. The response of automatic or cAMP-mediated, triggered ventricular rhythms to adenosine may be relatively specific since adenosine has no effect in catecholamine-facilitated reentrant VT (70) in patients with remote myocardial infarction, suggesting that the mechanism of catecholamine facilitation in these patients is independent of cAMP stimulation (71) . The effects of adenosine in catecholamine-induced reentrant VT due to acute ischemia has yet to be systematically evaluated.
The physiologic significance of adenosine-mediated accentuated antagonism is to restore a favorable 02 supply-demand ratio and, hence, to protect the myocardium from excessive catecholamine stimulation. The relationship between sympathetic stimulation and adenosine can be understood in terms of a feedback schema with a positive and negative limb. In the positive feedback limb, adenosine (signal) is released from myocytes in response to catecholamines and ischemia. Adenosine, in turn, attenuates (negative feedback limb) catecholamine release and end-organ responses at pre-and postsynaptic levels. Based on the results of this study and previous findings (67, 70) it appears that some catecholamine-mediated ventricular arrhythmias that occur under either normoxic or hypoxic conditions may result from inadequate feedback inhibition of sympathetic stimulation by adenosine and the parasympathetic nervous system.
